Rising sharply then falling back, the Shanghai Composite Index slightly increased by 0.03% in the first half of the day

robot
Abstract generation in progress

The three major A-share indices surged then pulled back; by the close this morning, the Shanghai Composite rose 0.03% to 3,881.17 points; the Shenzhen Component fell 0.20% to 13,325.83 points; the ChiNext Index declined 0.46% to 3,135.18 points; the STAR 50 Index increased 1.63% to 1,276.70 points; the Beijing 50 Index dropped 0.06% to 1,253.97 points.

In terms of liquidity, the People’s Bank of China conducted a 500 million yuan 7-day reverse repo operation today at an interest rate of 1.40%, unchanged from previous levels.

On the news front, the “Several Regulations on Short-term Trading Supervision” issued by the China Securities Regulatory Commission took effect today. The new rules further clarify the regulatory arrangements for major shareholders holding over 5% and senior management (including directors, supervisors, and senior executives) engaging in short-term trading. The core aim is to prevent insiders from exploiting informational advantages for short-term profits and to maintain market fairness.

U.S. leading AI model company Anthropic announced that its annual recurring revenue (ARR) exceeds $30 billion, a significant increase from $9 billion at the end of 2025. Demand for Claude continues to accelerate, surpassing the industry-disclosed OpenAI annual revenue of $25 billion.

In sectors, animal health, glyphosate, organic silicon concepts, and chemical raw materials led gains, while insurance, white goods, aviation airports, and aerospace performed poorly, dragging the market down.

By 2025, with no new capacity added in the industry and ongoing overseas capacity reductions, supply-side growth has officially peaked. On the demand side, emerging fields like new energy vehicles and photovoltaics maintain rapid growth, coupled with increased export volumes year-over-year, significantly improving the industry supply-demand balance. Against this backdrop, leading industry companies convened a development seminar, reaching agreements on dynamic pricing mechanisms and production cuts for organic silicon products, helping industry profits enter a recovery cycle.

Here, by integrating the latest research reports from over ten brokerages including Tianfeng, Anxin, and Guosen, we present brief profiles of four companies for fans’ reference only.

  1. Xin’an Co., Ltd.

The company is a dual leader in organic silicon and glyphosate. Amid anti-inflationary pressures, product prices are expected to bottom out and rise, with company performance likely to bottom out and reverse.

— Guojin Securities

  1. Hesheng Silicon Industry

Currently, the company has an annual capacity of 1.73 million tons of organic silicon monomers. As prices and profits of organic silicon products recover, the company, as an industry leader, is expected to continue benefiting.

— Everbright Securities

  1. Guibao Technology

With 27 years of deep cultivation in the organic silicon sealant industry, the company has developed into a new materials industry group with nine production bases and a high-end adhesive production capacity of 370k tons per year, building a rich product system including high-end organic silicon sealants, hot melt adhesives, silane coupling agents, and silicon-carbon anodes.

— Tianfeng Securities

  1. Luxi Chemical

The company continuously extends its industrial chain, gradually enhancing its comprehensive competitiveness, forming a relatively complete product chain in coal chemical industry, salt chemical industry, fluorosilicone chemical industry, and new chemical materials. The production synergy among these chemical product chains is good, with strong interrelation of production facilities, and some products can be recycled as downstream raw materials.

— Tianfeng Securities

Massive information, precise analysis, all on Sina Finance APP

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin